Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Losartan 2.5mg/ml oral suspension sugar free
0205052N0AAAIAI
|
Losartan potassium | Losartan potassium | Cardiovascular System | 1 |
|
Lotprosin XL 8mg capsules
0411000F0BGAAAE
|
Lotprosin XL | Galantamine | Central Nervous System | 1 |
|
LQD spray
20032000003
|
LQD spray | Wound Management & Other Dressings | Dressings | 1 |
|
Lumigan 300micrograms/ml eye drops
1106000AFBBAAAA
|
Lumigan | Bimatoprost | Eye | 1 |
|
Lungflute mucus clearance device
21010220116
|
Lungflute mucus clearance device | Other Appliances | Appliances | 1 |
|
Lyxumia 10micrograms/20micrograms treatment initiation pack
0601023AIBBACAC
|
Lyxumia | Lixisenatide | Endocrine System | 1 |
|
Macrodantin 50mg capsules
0501130R0BCAAAA
|
Macrodantin | Nitrofurantoin | Infections | 1 |
|
Macrodom sheath 127mm
22302903001
|
Macrodom sheath 127mm | Incontinence Sheaths | Incontinence Appliances | 1 |
|
Macrogol 4000 10g oral powder sachets sugar free
0106040X0AAAAAA
|
Macrogol 4000 | Macrogol 4000 | Gastro-Intestinal System | 1 |
|
Mag-100 capsules
0101010I0BJAAAB
|
Mag-100 | Magnesium oxide | Gastro-Intestinal System | 1 |
|
Mag-4 (magnesium 48.6mg (2mmol)) capsules
0905013G0BCABBM
|
Mag-4 | Magnesium glycerophosphate | Nutrition and Blood | 1 |
|
Mag-Ox 400 tablets
0101010I0BCAABI
|
Mag-Ox | Magnesium oxide | Gastro-Intestinal System | 1 |
|
Magnesium malate 300mg capsules
090501300AABJBJ
|
Generic compound preparation BNF 0905013 | Other magnesium preparations | Nutrition and Blood | 1 |
|
Magnesium oxide 375mg tablets
0101010I0AABRBR
|
Magnesium oxide | Magnesium oxide | Gastro-Intestinal System | 1 |
|
Magnesium sulfate 10% (magnesium 0.4mmol/ml) inj 10ml amp
0905013N0AAABAB
|
Magnesium sulfate (Supplements) | Magnesium sulfate | Nutrition and Blood | 1 |
|
MagnEss 160mg capsules
0101010I0BHABAC
|
MagnEss | Magnesium oxide | Gastro-Intestinal System | 1 |
|
MagnEss 500mg capsules
0101010I0BHACAY
|
MagnEss | Magnesium oxide | Gastro-Intestinal System | 1 |
|
MagnEss Gly 48.6mg (2mmol) capsules
0905013G0BHACBM
|
MagnEss Gly | Magnesium glycerophosphate | Nutrition and Blood | 1 |
|
Maguire urinal and adaptor 81-96cm
22900509001
|
Maguire urinal and adaptor 81-96cm | Urinal Systems | Incontinence Appliances | 1 |
|
Male pubic pressure urinal curved cone large curved
22902409037
|
Male pubic pressure urinal curved cone large curved | Urinal Systems | Incontinence Appliances | 1 |
|
Maloff Protect 250mg/100mg tablets
0504010U0BEAAAA
|
Maloff Protect | Proguanil hydrochloride with atovaquone | Infections | 1 |
|
Maneo 150mg modified-release tablets
040702040BUABAD
|
Maneo | Tramadol hydrochloride | Central Nervous System | 1 |
|
ManukaDress-T dressing
20030300030
|
ManukaDress-T dressing | Wound Management & Other Dressings | Dressings | 1 |
|
Marevan 3mg tablets
0208020V0BBABAB
|
Marevan | Warfarin sodium | Cardiovascular System | 1 |
|
Marol 150mg modified-release tablets (Morningside)
040702040BNABAD
|
Marol | Tramadol hydrochloride | Central Nervous System | 1 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.